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1. Introduction    
Small biomolecules (< 2 kDa) are crucial to a wide range of biochemical processes in the 
human body. Their diverse functions can include acting as hormones, neurotransmitters and 
pheromones. Small molecules are typically found in the blood stream and their 
concentrations can often be indicative of the biochemical functioning of the organism. This is 
particularly true of the steroids, a major class of small molecule hormone.  
Measurement of steroid concentrations is commonly performed to track the progression of 
the fertile cycle, to detect pregnancy and to help diagnose hormonal diseases (Clark et al., 
1998). Immunoassay techniques dominate the market for hormonal assays. These assay kits 
utilise the highly selective binding of an antibody to its target antigen to detect small 
molecule analytes in highly complex matrices. Typically, for small molecules, the assay will 
consist of a plate or tube onto which the antibody is immobilised and the sample is passed 
over the plate surface along with an aliquot of labelled antigen. The label used is either 
radiochemical (radioimmunoassay (RIA)) or enzyme-based (enzyme-linked immunosorbent 
assay (ELISA)). The labelled antigen occupies the un-bound sites on the immunoassay plate 
and the signal obtained from the label by either measuring the resultant radiation, or 
through enzyme catalyzed colour changes, gives a standard curve from which the 
concentration of the free analyte can be determined. 
Small molecule targets are typically found in complex matrices such as blood and saliva 
where high molecular mass components predominate. These include proteins that can in 
some cases bind to the steroid hormone of interest. Their large size relative to the target 
antigen can also serve to sterically impede antibody binding to the steroid. Furthermore, 
large molecule contaminants can also bind to immunoassay surfaces causing biofouling that 
can further interfere with assay results. 
Despite their widespread application, RIA and ELISA are practically limited to use in 
centralised laboratory environments where careful control of the experimental conditions 
can be exercised. They typically involve multiple steps that require trained operators and in 
the case of RIA they involve the use of radioisotopic labels that require specialised handling 
and represent a significant health hazard. Analysis is also very labour intensive and 
consequently quite expensive. Samples therefore must be transported to a laboratory and 
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testing and processing of results typically takes several hours-days. This arrangement is 
inadequate for a wide range of applications that need results in much shorter timeframes. 
To help address these issues, there has been much research devoted to the development of 
immunochromatographic test strip technology (Weller, 2000). This technology has been 
utilised for detection of drug residues (Chen et al., 2009) and drugs of abuse by transferring 
the immunoassay process onto a single-use test strip that generates a colour response after 
the sample has flowed over the immobilised protein conjugate. Such tests however, are 
largely semi-quantitative and so can be of limited use when a concentration result is 
required rather than a simple yes/no answer. 
Biosensors offer a very promising means of achieving more versatile determination of small 
molecule concentrations in diverse matrices. A biosensor is an instrument that utilises a 
biomolecule/s, such as an enzyme or antibody, to interact with the target molecule being 
measured. From this interaction an electrical signal is then generated which can be used to 
determine the concentration of the target compound. Biosensors are typically classified 
according to the biochemical interaction used and the method of transduction. For detection 
of small molecules, antibody based biosensors are a logical choice as they retain the excellent 
specificity of antibodies allowing for detection in complex matrices, including those with a 
number of structurally similar compounds present in the same sample, as is the case with 
the steroid hormones. Furthermore, their relatively high binding affinities allow efficient 
uptake of the analyte from the sample and thus maximise the number of binding events and 
the biosensor signal. High quality antibodies are widely available for a broad range of small 
molecule analytes, including most of the physiologically significant steroid hormones. 
When we examined the range of transduction technologies available for small molecule 
biosensing, we decided to investigate the use of the quantum optical-electrical phenomenon 
known as surface plasmon resonance (SPR). When a photon of light is incident on a noble 
metal surface (typically gold or silver) it can couple with the electrons in the metal, exciting 
the electrons and causing them to move as a single electrical entity known as a plasmon 
which propagates parallel to the metal surface. As the plasmon oscillates it generates an 
electric field that extends about 300 nm out from the metal surface (Homola et al., 1999). At a 
particular angle where the energy transfer from the photon to the plasmon is well matched a 
resonance occurs, significantly increasing energy transfer from the photon to the plasmon 
and causing a corresponding decrease in reflectance.  If mass is bound to the surface within 
this 300 nm range then it perturbs the plasmon and, for a photon of fixed wavelength, shifts 
the resonance angle. If the plane of the metal surface is fixed, then the resonance wavelength 
can be identified by scanning through a range of angles of incidence for the photon and 
determining the resonance angle (Mullet et al., 1998). An SPR biosensor effectively measures 
minute changes in refractive index corresponding to binding events on the sensor surface 
(Homola, 2008). SPR biosensors can typically achieve resolutions down to 1 resonance unit 
(RU) which is 1 x 10-6 refractive index units (Stenberg et al., 1991). SPR biosensors can 
effectively detect binding by molecules as small as about 2 kDa, but smaller molecules 
generate insufficient changes in bound mass and so cannot be directly measured adequately. 
This poses particular challenges for detecting small molecules. In this case it is necessary to 
detect the binding of an antibody to an analyte conjugated sensor surface or to tag the small 
molecule with a large molecular mass tag and use this to bind to un-bound antibody sites on 
the sensor surface. Once the binding event/s have taken place, then the sensing surface can 
be returned to its original state by application of a suitable regeneration cocktail, allowing 
some re-use of the surface. 
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BIAcore SPR instruments have been widely used for years for the analysis of biomolecular 
interactions. It is extensively applied as a research tool to examine antibody / antigen 
(McCormick et al., 2004; Kubitschko et al., 1997), oligonucleotide / complementary 
oligonucleotide (Kai et al., 1999), receptor / target (Zhang et al., 2004) and host / guest 
(Chen et al., 2002) interactions. These instruments contain sophisticated microfluidics and 
temperature control units and range from the conventional four channel versions such as 
BIAcore 3000, to the more recent array format in the BIAcore Flexchip. The instruments use 
chips which contain the gold sensing surface and can be docked and un-docked from the 
main instrument as required. The work discussed in this chapter uses either a BIAcore 2000 
or 3000 in the 4-channel format with a carboxymethylated (CM) dextran coating. 
SPR biosensor assays have the advantages that binding data can be collected in real-time as 
the sensorgram (plot of response vs. time) is generated and so there is no need to wait for 
the signal development of an entire immunoassay plate to obtain results. This makes the 
technology particularly amenable to use in applications where data is required to inform 
decisions in near-real-time, such as in the diagnosis of disease or in the study of human 
hormonal responses. Furthermore, SPR assays are semi-automated. Once the samples are 
loaded into an instrument such as a BIAcore, then a wizard program can run the assay 
automatically and feed results to your desktop. With pre-prepared standards very little 
pipetting is required and this significantly reduces costs. SPR assays also do not use any 
radioactive labels. Increasingly, SPR biosensor technology is improving to the extent that a 
number of more compact and affordable options are now appearing on the market thus 
beginning a wider dissemination of the technology beyond large, well-funded centralised 
laboratories. 
Potentially SPR is a very sensitive transduction technique where only small changes in 
refractive index are required to generate signal. This means that provided the immunoassay 
format and surface coating chemistries are well-designed, very sensitive assays can be 
achieved. However, in the case of small molecule immunoassay, the lack of mass in the 
analyte means that specialised enhancement technologies need to be applied to achieve the 
very low detection limits needed for measurement at the physiologically relevant 
concentrations found in certain biological fluids, including saliva. 
It is very easy for steric hindrance to occur between the small molecule and the large 
antibodies used or between the small molecule and the sensing surface. If the analyte is 
sterically impeded from binding to the antbody this reduces the sensor signals that can be 
obtained and worsens the sensitivity of the immunoassay. Given that an SPR sensor detects 
bound mass on the sensor surface, if large molecules bind non-specifically to the surface 
then they will generate an SPR signal which can obscure the signal results from specific 
immunoassay binding of the analyte. This risk is particularly high if the sample matrix 
contains high concentrations of high molecular mass species, such as in the case of saliva 
which is rich in mucins. For a given assay it is very beneficial to be able to use the same 
biosensor surface over and again many times. This approach means that the need for 
calibrating different sensor surfaces is minimised, cost of consumables is reduced and risk of 
failure of the sensing surface during crucial analyses is mitigated. Most SPR sensor surfaces 
rely upon self-assembled monolayers (SAMs) to conjugate small molecules or antibodies to 
the sensor surface. This method of attachment lacks longer-term stability as do most direct 
immobilisations of proteins onto sensor surfaces. Typically such SAM surfaces only last 
about 100-400 binding and regeneration cycles (Yuan et al., 2007). 
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Given these significant challenges faced by small molecule SPR immunosensing it is very 
important to consider how such assays can be rationally designed to overcome problems of 
steric hindrance, biofouling, sensor surface stability and signal enhancement for greater 
sensitivity. In this chapter we examine the strategies taken in our laboratories to overcome 
these challenges and to help make SPR immunosensing a more practical technique for 
sensitive detection of small molecules, even in complex matrices. 
2. Rational design of steroid conjugates 
To optimise the sensitivity of SPR immunoassays of the steroid hormones, it is necessary to 
achieve maximum specific antibody binding to the antigen-conjugated sensor surface. The 
first step in ensuring this is to allow free access by the antibody to the specific parts of the 
steroid molecule that the antibody recognises, that is the epitopes. To do this one must 
conjugate the steroid through a position distant from these critical functional groups and not 
conjugate through an existing functional group. For the steroids, this can be done by 
conjugating to the A-ring 4-position using the formation of a thioether linkage (Fig. 1). This 
technique was selected after SPR analysis revealed much stronger binding to the 4-position 
for progesterone than was obtained through the more conventional 7-position (Wu et al., 
2002) (Fig. 2).  
In the case of estradiol, another conjugation technique utilising a Mannich reaction to 
conjugate at the 2-position of the A-ring was found to be equally useful in retaining strong 
binding responses. This was in contrast to hemisuccinate conjugation through the hydroxyl 
group at the 3-position, which gave only 2% as much binding (Mitchell et al., 2006). 
The next factor to consider is the length of the intermediate linker that spaces the antigen 
from the sensing surface (Bieniarz et al., 1996). The linker should project the antigen into the 
flow of fluid that passes through the biosensor flow cell and so allow optimal presentation 
of the immobilized antigen to the antibody thus ensuring maximum sensor signal. We have 
considered the effects of incremental changes in linker length for progesterone – protein 
conjugates, examining linkers of 4-, 11- and 18-atoms in length (Wu et al., 2002). The linker 
length was found to be crucial to the amount of antibody binding in the SPR flow-through 
biosensor format with binding responses increasing up to 18-atoms in linker length (Wu et 
al., 2002). Based on these observations, an oligoethylene glycol linker was attached to the 
steroid at the 4-position through a thioether bridge. This produced a 19-atom linker chain 
(Mitchell et al., 2005). Oligoethylene glycol is well known as being non-immunogenic 
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Fig. 1. Synthesis of progesterone-4-thioether conjugate for attachment of linkers 
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Fig. 2. SPR sensorgrams showing the binding of progesterone – protein conjugates to a 
progesterone monoclonal antibody (mAb) functionalised surface. OVA: ovalbumin, 2-OVA: 
conjugate through the 7-position, 1-OVA: conjugate through the 4-position, 4-OVA: 4-
position conjugate with 11-atom linker, 6-OVA: 4-position conjugate with 18-atom linker. 
Reprinted from Steroids, 67, Mitchell, J. S.; Wu, Y.; Cook, C. J.; Main, L. (2002) Evaluation of 
progesterone-ovalbumin conjugates with different length linkers in enzyme-linked 
immunosorbent assay and surface plasmon resonance-based immunoassay. 565-572, 2002, 
with permission from Elsevier. 
(Kurusu et al., 2003) and biocompatible (Otsuka et al., 2003) thus minimising non-specific 
binding to the linker. It is hydrophilic and thus allows good projection of the antigen into 
the aqueous mobile phase. Furthermore, it has high chemical stability and the length can be 
incremented as required by addition of more ethylene glycol units. Attachment to one end 
of the chain is achieved by protecting the amine at the opposite end by attachment of a t-
butoxy carbonyl group which can be conveniently removed at the time of immobilisation. 
3. Covalent linker conjugation technology 
3.1 Immobilization 
High immobilization stability can be achieved by use of a totally covalent immobilisation of 
the steroid antigen to the sensor surface. In these studies, the most effective means of 
achieving this was to utilize a carboxymethylated (CM) dextran polymer coating applied to 
the gold surface. This dextran hydrogel extends for about 100 nm from the gold surface and 
is highly porous, giving a very high surface area. The polymer is studded with carboxylic 
acid groups which can be conveniently used as anchor or immobilisation points for covalent 
attachment of steroid-linker conjugates. This attachment is achieved by the formation of an 
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amide linkage between the carboxylic acid groups and the primary amines at the end of the 
oligoethylene glycol linkers. This can be further facilitated by use of N-hydroxysuccinimide 
(NHS) activation of the carboxylic acids. 
Immobilization was achieved by simply flowing a mixture of NHS and N-ethyl-N-(3-
dimethylaminopropyl)-carbodiimide (EDC) over the CM dextran surface to activate it and 
then flowing the steroid linker conjugate. This is ideally performed at low flow rates (5 
μL/min) to ensure maximum conjugation to the sensor surface. This technique provides 
high binding capacity surfaces without the need to disassemble the chip. Finally, 
ethanolamine solution (pH 8) can be passed over the surfaces to cap any un-conjugated 
carboxylic acid groups and so prevent them from reacting with proteins in the samples. 
3.2 Surface stability and regeneration 
To achieve a high throughput of samples and standards over a single surface, it is necessary 
to have very high sensor surface stability as the surface must be able to withstand multiple 
binding and regeneration cycles. The regeneration process involves exposing the surface to 
harsh regeneration “cocktails” which chemically remove the bound antibodies. The cocktails 
used in this work are typically 50 mM NaOH with 20%v/v acetonitrile, providing a 
combination of high pH and a chaotrophic reagent. Despite exposure to such a harsh 
mixture, progesterone conjugated surfaces are able to withstand more than 1100 binding 
and regeneration cycles without appreciable loss of binding capacity (Mitchell et al., 2005). 
This greatly extends the lifetime of a single sensor surface and allows extensive re-use 
without the need for immobilization of a fresh surface and in so doing, significantly reduces 
the costs per assay cycle.  
4. Assay format and gold nanoparticle signal enhancement 
The assay format adopted was a competitive inhibition assay. In this format, the small 
molecule analyte was covalently immobilised on the surface. The sample containing the 
small molecule was then mixed with a primary antibody raised against the analyte and the 
mixture injected over the sensor surface. Primary antibody that had not bound the “free” 
sample antigen, bound the surface immobilized antigen thus producing a refractive index 
change on the surface (Fig. 3). This SPR signal is inversely related to the concentration of the 
“free” antigen and a standard curve can be produced that takes the form of an S-curve. 
The sensitivity of the assay can be assessed as the amount of signal change achieved per unit 
of analyte concentration change and the limit of detection as the minimum concentration 
that can be statistically distinguished from the blank. Lower concentrations of the analyte 
can be detected by reducing the concentration of the primary antibody as less free antigen 
would be required to inhibit antibody binding to the antigen-immobilized surface. The 
problem with this approach in SPR, is that this will also reduce the signal by reducing the 
bound mass on the surface. To achieve a highly sensitive assay, it is therefore crucial to 
minimise the primary antibody concentration whilst retaining high signal. 
When the above assay design was applied to the SPR biosensor as described, it gave assays 
with a LOD of approximately 1 ng/mL in the case of progesterone. Whilst this LOD is 
suitable for measurement of steroids in human blood serum, it is far too high to measure 
steroids in other matrices such as saliva, where concentrations are typically 1% of those 
found in blood. To shift the assay curve to lower concentrations, it was necessary to further 
reduce the primary antibody concentration. To retain sensor signal, strategies for labelling 
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Fig. 3. Schematic showing the steroid immobilised SPR sensor surface, binding of primary 
antibody and labelling with secondary antibody – gold nanoparticle conjugate. 
the binding interaction were applied. First, a secondary antibody that recognises the 
primary antibody, was bound in a separate binding step to add signal to the binding 
interaction and allow significant reductions in the concentration of the primary antibody 
(Fig 3.). LOD of 20.1 pg/mL could now be obtained for progesterone and signal was 
enhanced 8.1-fold (Mitchell et al., 2005) (Fig. 4).  
As well as using secondary antibody there are other means of adding high mass tags to the 
binding interaction. Gold nanoparticles have a high mass contained in nanospheres the 
diameter of which can be altered as required between about 1 nm – 100 nm by altering the 
conditions of their synthesis. This size range is ideal for tagging antibodies and furthermore, 
gold nanoparticles can be readily conjugated to proteins such as antibodies through charge 
interactions. Gold nanoparticle enhancement has been applied to large molecule 
immunoassays (Gu et al., 1998; Lyon et al., 1998; White & Rosi, 2008) but significant steric 
challenges exist for its use with small molecules. Gold nanoparticles of 25, 45, 55 and 70 nm 
diameters were examined as tags for secondary antibodies for signal enhancement in small 
molecule SPR immunosensing. 25 nm nanoparticles were found to give the highest signal 
enhancement and were applied in a progesterone assay. Signal enhancement further 
increased to 13-fold and the LOD could be reduced to 8.6 pg/mL for progesterone (Fig. 5) 
(Mitchell et al., 2005). By application of gold-secondary antibody signal enhancement, the 
LOD could thus be reduced by more than two orders of magnitude (Mitchell et al., 2005),  
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Fig. 4. Plots of SPR response (RU) vs. antibody concentration (μg/mL) for unenhanced mAb 
only assay (Æ) and secondary antibody enhanced assay (̈). Reprinted from Analytical 
Biochemistry, 343, Mitchell, J. S.; Wu, Y.; Cook, C. J.; Main, L. Sensitivity enhancement of 
surface plasmon resonance biosensing of small molecules. 125-135, 2005, with permission 
from Elsevier. 
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Fig. 5. Progesterone SPR immunoassay standard curves for assay without signal 
enhancement (”) and with gold nanoparticle signal enhancement (»), showing 
improvements in LOD. Reprinted from Analytical Biochemistry, 343, Mitchell, J. S.; Wu, Y.; 
Cook, C. J.; Main, L. Sensitivity enhancement of surface plasmon resonance biosensing of 
small molecules. 125-135, 2005, with permission from Elsevier. (RSC) (www.rsc.org) 
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allowing sensitive detection of steroid hormones at the concentrations typically found in 
human saliva. The signal enhancement arising from the gold labelling could result not only 
from the added mass but also from cooperative plasmon coupling between the gold 
nanoparticles and the underlying gold sensor surface. This effect has been suggested before 
with large molecule binding targets (Lyon et al., 1999). 
Using bulky nanoparticles to enhance SPR signal strength, adds to the potential for steric 
hindrance in immunoassays of small molecules. These assays were constructed around a 
“double spacer” system whereby spacers or linkers project the antigen out from the sensor 
surface and hold the primary antibody out from the gold surface, thus allowing space for 
the antigen / antibody interactions and ensuring optimal sensor signal. Non-specific 
binding from the conjugated gold nanoparticles could be reduced significantly by the 
addition of polyethylene glycol (PEG)-400 or PEG-4000 (Mitchell et al., 2005). By using a 25 
nm gold nanoparticle, the risk of the colloid settling or aggregating over the course of the 
assay is minimised. Bovine serum albumin (BSA) could also be used to further reduce non-
specific binding (Mitchell et al., 2005). 
5. Small molecule analytes 
The immunobiosensor format outlined in the previous sections is quite generic and can be 
applied to a wide range of small molecules provided they have a suitable site for 
conjugation and have high affinity monoclonal antibodies available (Fig. 6). The SPR 
immunobiosensor approach outlined was first tried with progesterone as a model 
compound. Progesterone has well developed monoclonal antibodies and its measurement is 
of significant interest in the monitoring of oestrous cycles in animals and in the early 
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Fig. 6. Structures of steroid analytes covalently conjugated to SPR sensor surface through the 
4-position 
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identification of pregnancy. The assay concept was later extended to 17β-estradiol which has 
an aromatic A-ring and so required a slightly different approach to the attachment of the 
thioether unit. Assays using secondary antibody enhancement gave an LOD of 25 pg/mL 
for 17β-estradiol (Mitchell et al., 2006). Other steroid hormones measured using this 
technique include cortisol (Mitchell et al., 2009) and testosterone (Mitchell & Lowe, 2009). 
Cortisol detection can be used in the diagnosis and management of conditions such as 
Addison’s disease (Lovas & Husebye, 2003) and as an indicator of stress (Riad et al., 2002). 
Testosterone is the principal male sex hormone and its concentrations are of interest in 
sports physiology (Crewther et al., 2006). For cortisol, an LOD of 13 pg/mL was obtained in 
buffer with secondary antibody enhancement (Mitchell et al., 2009) and for testosterone it 
was 35 pg/mL (Mitchell & Lowe, 2009). Both cortisol and testosterone used analogous 
conjugation techniques to that of progesterone. When the testosterone assay utilised gold 
nanoparticle enhancement, the LOD dropped further to 23 pg/mL (Mitchell & Lowe, 2009). 
Another positive feature of these assays is that the primary monoclonal antibody 
concentrations used are minimised to improve assay LOD. This also serves to lower the 
costs per assay and so individual determinations can usually be done for <NZ$2 in materials 
cost. The volumes of sample required are also very low (typically 50 μL) making these 
techniques amenable to applications where samples are very precious. 
Extending the range of compounds beyond the steroids, the catecholamine dopamine was 
also conjugated to an SPR surface using an OEG linker attached to a mercaptothioether 
moiety conjugated ortho to a phenol group (Mitchell et al., 2007) (Fig. 7). This allowed 
conjugation at a point distant from characteristic functional groups and without 
compromising existing functional groups. Antibody binding interactions were then studied 
in this flow-through biosensor format and various conjugation techniques compared and 
contrasted (Mitchell et al., 2007). 
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Fig. 7. Covalent conjugation of dopamine to the SPR biosensor surface utilising a CM-
dextran polymer 
As well as examining SPR using a continuous gold underlayer as the sensor surface, the use 
of gold nanohole array substrates for biosensors are attracting attention (Brolo et al., 2004; 
Gao et al., 2007). They are of interest for use in biosensors as they have a lower 
functionalisation area giving rise to increased sensitivity, a simple optical set-up with 
transmission measurement of well-defined spectral features and they allow for optical field 
concentration giving interesting enhancement effects.  As a precursor to their use in 
immunobiosensors, immunochemical interactions were studied using a gold nanohole array 
where the signal response is expressed as a movement in the plasmon transmission peak of 
the array which can be simply measured using a UV-visible spectrophotometer (Sharpe et 
al., 2008). In this case, monoclonal antibody binding to immobilised cortisol could be clearly 
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detected as could enhancement with gold-nanoparticle labelled secondary antibody (Fig. 8). 
The system could also be regenerated and had low non-specific binding from the gold 
nanoparticles (Sharpe et al., 2008).  
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Fig. 8. Schematic showing a gold nanohole array functionalised with analyte (cortisol) 
conjugated to a thiol linker. The analyte is bound by a primary monoclonal antibody and 
then labelled with a secondary antibody-nanogold conjugate. Reprinted with permission 
from Sharpe, J. C.; Mitchell, J. S.; Lin, L.; Sedoglavich, N.; Blaikie, R. J. (2008) Anal Chem, 80, 
6, 2244-2249. 2008 American Chemical Society. 
6. Measurement in saliva 
Human saliva contains very high concentrations of high molecular mass components such 
as mucins. These compounds can bind to SPR sensor surfaces and generate erroneous 
responses. This problem is particularly acute for small molecules, such as the steroid 
hormones, present at very low concentrations. Cortisol is present typically at 0.1 – 10 ng/mL 
in human saliva and testosterone at 29-290 pg/mL (Ellison et al., 2002). Measurement in 
saliva is particularly advantageous as it allows non-invasive detection of small molecules 
and regular sampling. Samples ideally need to be analyzed rapidly in near real-time, so 
chemical extraction and extensive pre-treatment of samples are not options.  
Standards of cortisol and testosterone spiked into stripped human saliva could be used for 
the measurement of salivary hormonal concentrations. These standards could be passed 
through a BIAcore SPR instrument without clogging of the microfluidics (Mitchell et al., 
2009). In the case of cortisol, saliva samples from human subjects were analyzed in the 
BIAcore without extensive pre-treatment through the addition of sodium dodecyl sulphate 
(SDS) to the antibody diluent at carefully controlled concentrations. The SDS is thought to 
minimise adhesion of salivary mucins to the sensor surface through charge repulsion, but at 
the concentrations used it did not affect the antibody or compromise the assay sensitivity 
greatly (Mitchell et al., 2009). The non-specific binding was reduced to a consistent and low 
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level enabling an assay curve to be formed without significant interference from high-
molecular mass species (Mitchell et al., 2009). An LOD of 49 pg/mL was obtained for 
salivary cortisol, well below that required for analysis of saliva samples. Additionally, a 
strong signal sensitivity of 162 RU.mL/ng was attained allowing accurate discrimination of 
concentrations ranging to below 1 ng/mL (Mitchell et al., 2009). Despite the use of SDS, 
interassay CVs of 13.5% were achieved, comparable to many ELISA (Mitchell et al., 2009; 
Mitchell et al. 2004). No clogging of the microfluidics was observed despite the high 
viscosity of saliva. To ensure the accuracy of the salivary cortisol measurements, samples 
from 40 healthy male volunteers were compared to results from RIA. The slope of the 
correlation line was close to 1 with an r = 0.94, showing good agreement between the two 
techniques (Mitchell et al., 2009) (Fig. 9). Binding and regeneration steps could be completed 
in 10 min per sample thus allowing for a fast throughput of samples. Another advantage of 
this method is that pre-concentration of samples is avoided as the technique has sufficient 
sensitivity to measure samples without complex pre-treatment (Mitchell et al., 2009). 
Furthermore, measurement can be made in small sample volumes (50 μL of sample is 
sufficient). 
This SPR technique for measurement of salivary cortisol provides a useful means of 
monitoring hormone concentrations non-invasively in near-real-time and can be applied to 
both diagnostic and stress monitoring applications. As the technique is largely generic, it 
can be extended to other target small molecules found in human saliva. A later cortisol SPR 
study using a different sensor surface approach has failed to achieve comparably low LOD 
(Frasconi et al., 2009). 
 
 
Fig. 9. Correlation plot comparing concentration determinations made by the SPR cortisol 
immunoassay and salivary cortisol radioimmunoassay. Rapid ultrasensitive measurement 
of salivary cortisol using nano-linker chemistry coupled with surface plasmon resonance 
detection. Analyst, 134, 2, 380-386 – Reproduced by permission of The Royal Society of 
Chemistry 
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7. Context in wider plasmonic biosensor research 
The ever widening field of plasmonic biosensor research largely falls into three main areas. 
1. The use of SPR to study biomolecular interactions. This includes antibody, 
oligonucleotide, receptor and enzyme research and involves using SPR as a tool to probe 
biological systems. 2. The study of plasmon fields and their relationship to the noble metal 
surfaces from which they emanate (Lyon et al., 1999). This typically involves using 
quantum, electrical and optical physics to systematically investigate the plasmon resonance 
phenomenon at a fundamental level. 3. The use of SPR biosensors to detect large molecule 
targets, including proteins and DNA (Huang et al., 2008). The use of SPR for the sensitive 
measurement of low concentrations of small molecules has not received as much attention 
as assays for proteins and oligoneucloetides. There is now growing research interest in 
improving small molecule SPR immunoassay through design of the sensor interface 
(Mitchell et al., 2005; Miura et al., 2008; Shankaran et al., 2007). Recent studies have 
examined the use of SAM layers combined with protein conjugates to fabricate sensor layers 
for a herbicide (2,4-D, LOD of 10 pg/mL) (Kim et al., 2006), benzaldehyde (Gobi et al., 2007 
b) and a steroid hormone (progesterone, LOD of 4.9 pg/mL) (Yuan et al., 2007) either with 
or without protein or nanogold enhancement.  This approach has also been applied to 
measurement of the antimicrobial chloramphenicol (Yuan et al., 2008). Further work using 
direct covalent immobilisation to SAMs for TNT analysis has also been combined with 
secondary antibody signal enhancement (LOD of 50 pg/mL) (Mizuta et al., 2008) and a 
similar strategy developed for detection of benzaldehyde using PEG linker chains (Gobi et 
al, 2007 a). Immobilisation of histamine through a SAM layer without enhancement has 
yielded poorer LOD (3 ng/mL) (Li et al., 2006). Gold nanoparticle enhancement has also 
been used to improve LOD in the immunoassay of the metabolite estriol-16-glucuronide 
(LOD of 14 pg/mL) (Jiang et al., 2009) using protein conjugate immobilized on CM dextran. 
A protein conjugate to a small molecule dye has also been used as the high mass labelled 
antigen in a competitive SPR immunoassay with immobilised antibody (Aizawa et al., 2007) 
and biotin-BSA has been used as a high mass label for 2,4-D immunoassay (Kim et al., 2007).  
With gold nanoparticle enhancement of small molecule SPR immunoassays now well 
established, it is hoped that it will be successfully applied to an even broader range of 
compounds. The issue of biofouling in small molecule SPR is also receiving attention but 
often the techniques used involve total removal of the background matrix by time-
consuming methods such as flow filtering where blockages can occur and LOD are too high 
(Stevens et al., 2008) or else extensive dilution of samples (Gillis et al., 2002) which worsens 
the practical LOD.  
By combining surface and conjugation chemistry with immunology and optics, it is possible 
to create new sensor interfaces that offer significantly improved detection of small 
molecules, not only in buffer but also in real biological samples. The research detailed in this 
chapter represents several advances in the use of SPR to detect small molecules of biological 
significance at very low concentrations and particularly in a complex biological matrix. 
8. Conclusions and future research 
The sensitive measurement of very low concentrations of small molecule analytes is of great 
value in the diagnosis of disease, study of human and animal physiology and the 
monitoring of product quality and environmental integrity. Many small molecules are 
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routinely measured by traditional RIA or ELISA in expensive, time-consuming and 
centralised processes. In this chapter we have examined how SPR immunobiosensors can be 
used to measure very low small molecule concentrations accurately, quickly, affordably, 
with low labour requirements and even in complex biological matrices on highly re-usable 
sensor surfaces. The use of chemical linkers to covalently immobilise steroid antigens to the 
sensor surface allows the surface to be re-used many times even under harsh regeneration 
conditions. By selecting a conjugation position and linker length that optimises antigen 
presentation in the flow-through assay format, antibody binding can be maximised and high 
signal sensitivities obtained. The use of hydrophilic and non-immunogenic linkers also 
improves specific binding response. Secondary antibody labelling of the primary 
monoclonal antibody binding interaction is a convenient means of enhancing the sensor 
signal and further reducing LOD. Enhancement is further increased by the use of gold 
nanoparticles which add further mass and cooperatively enhance the plasmon shift. As the 
technology is generic, it can be applied to a wide range of small molecule targets. The 
application of this technology to the sensitive measurement of salivary cortisol has been 
demonstrated with the addition of SDS surfactant to minimise non-specific binding and 
allow measurement without chemical extraction or extensive pre-treatment of samples. 
To achieve the next generation of SPR biosensors for small molecules, future research will 
likely focus on expanding the types of small molecule analyte conjugated to the sensor 
surface and on examining alternative gold substrate designs to further improve sensitivity. 
The covalent nanolinker approach described in this chapter has been applied to a range of 
steroid hormones but it is also amenable to use with other small molecules such as 
pesticides, pharmaceutical residues and human and animal metabolites. Given that new 
regulations increasingly require sensitive measurement of many of these compounds, there 
is a very real role for SPR biosensors to play in semi-automated, high-throughput analysis of 
environmental and food samples. Biomedical testing laboratories may increasingly look to 
semi-automated alternatives to traditional plate-based assay formats as their sample loads 
increase for diagnosis and monitoring of medical conditions. Accessing new classes of 
analytes is limited only by the conjugation technique used to attach the linker to a point 
distant from existing functional groups. Alternative gold substrates that are attracting much 
attention include the use of “nano-islands” of deposited noble metal. These islands can 
generate localised surface plasmons (LSPs) particularly around their vertices and can 
generate very steep plasmon field gradients which could potentially result in greater 
sensitivity. Another emerging technique is the use of gold nanohole arrays as described 
above. Here, optical field concentration around the nanoholes offers the potential for further 
improvements in sensitivity. 
When developing biosensor technologies for highly sensitive detection of small molecules, it 
is crucial to consider the chemistry of the sensor / sample interface, as it is here that the 
critical binding interactions needed for measurement take place. By rationally designing this 
interface, one can greatly improve the performance of the biosensor by maximising specific 
binding interactions, minimising non-specific binding and biofouling and creating 
chemically stable and highly re-usable sensor interfaces. This approach combined with the 
rapid advances in plasmonic transduction technology, particularly plasmonic substrate 
design, offer great promise for even more sensitive and reliable small molecule biosensors. 
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